Macrophage-targeted drug delivery depot for obesity and type 2 diabetes

Who could benefit from this research

What this research studies

This project aims to create a biodegradable, long‑acting depot that releases drugs directly to fat‑tissue macrophages to modify inflammation and improve metabolic health. It builds on prior work showing that macrophage-targeted nanocarriers can alter fat tissue biology and reduce weight and diabetes markers in animal models. The research plan includes translating these delivery depots toward human use and developing imaging methods to monitor treatment distribution and effectiveness. If successful, it could offer a patient-friendly option that reduces the need for frequent dosing while aiming to improve diabetes-related outcomes.

Why it matters

Where this research is happening

• University of Illinois at Urbana-Champaign
  Champaign, United States Active

Researchers

• Principal investigator: Smith, Andrew Michael — University of Illinois at Urbana-Champaign
• Study coordinator: Smith, Andrew Michael

Related research

Other NIH-funded projects on the same topics.

• Ksr2 and obesity-related hearing loss in a mouse model: what it means for veterans

  This project studies how obesity and type 2 diabetes affect hearing using a mouse model to identify ways to protect hearing in people with metabolic problems.

  NIH research VA Loma Linda Healthcare System · Loma Linda, United States · NIH-11411893

• Epitranscriptomics in obesity and type 2 diabetes

  Researchers are studying how gene activity changes in fat tissue and other organs to better understand obesity and type 2 diabetes, with the goal of finding new ideas for treatment.

  NIH research Joslin Diabetes Center · Boston, United States · NIH-11398955

• New medicines to help people lose weight safely and protect the pancreatic cells that control blood sugar

  A funding opportunity to develop a new pill that helps people lose weight without muscle loss and protects the insulin-producing beta cells in the pancreas.

  NIH research Emmyon, INC. · Rochester, UNITED STATES · NIH-11378372

• Predicting obesity-related diabetes and wound healing with math models

  A math-based model is being built to better understand how obesity drives type 2 diabetes and slow wound healing in adults.

  NIH research Rochester Institute of Technology · Rochester, United States · NIH-11377524

• Comparing bariatric (weight‑loss) surgery with GLP‑1 and SGLT‑2 diabetes medicines for people with obesity and type 2 diabetes

  This project compares long-term benefits and safety of weight‑loss surgery versus GLP‑1 and SGLT‑2 diabetes medicines for adults who have obesity and type 2 diabetes.

  NIH research Kaiser Foundation Research Institute · Oakland, UNITED STATES · NIH-11290742

• How obesity and type 2 diabetes that start in youth affect the brain's blood vessels and thinking

  Doctors will compare brain scans, blood flow, and thinking skills in teens with early-onset type 2 diabetes, teens with obesity but no diabetes, and lean peers to learn how diabetes affects the brain.

  NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11264837

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.